8 results match your criteria: "Northwest Lipid Research Center[Affiliation]"
Ann N Y Acad Sci
May 1997
Northwest Lipid Research Center, Seattle, Washington 98104, USA.
Am J Ther
November 1996
Northwest Lipid Research Center, University of Washington, Seattle, WA.
OBJECTIVE: To determine the efficacy and safety of pravastatin in the treatment of subjects with Type III hyperlipoproteinemia. DESIGN: Randomized, double-blind, placebo-controlled, crossover study. SETTING: Four lipid research clinics in the United States.
View Article and Find Full Text PDFClin Chem
February 1990
Northwest Lipid Research Center, Harborview Medical Center, Seattle, WA 98104-2499.
A common accuracy-based standardization program is indispensable for establishing reference intervals for the clinical use of apolipoproteins. The development and distribution of reference materials and quality-control materials that do not exhibit matrix effects between methods is essential to the standardization process. We examined the suitability of lyophilized material as a common reference material for the measurement of apolipoproteins A-I and B.
View Article and Find Full Text PDFJ Automat Chem
July 2011
Northwest Lipid Research Center 2121 N 35th St Seattle Washington 98103 USA.
J Lipid Res
September 1989
Department of Medicine, University of Washington School of Medicine, Northwest Lipid Research Center, Seattle 98104.
A monoclonal antibody-based direct binding enzyme-linked immunosorbent assay (ELISA) for apoprotein (apo) B-100 has been developed for use as a reference method. The assay uses the two well-characterized monoclonal antibodies, MB24 and MB47. MB47, which recognizes an epitope at the low density lipoprotein (LDL) receptor-binding domain of apoB and is specific for apoB-100, is bound to the microtiter plate as the capture antibody.
View Article and Find Full Text PDFClin Lab Med
March 1989
Northwest Lipid Research Center, University of Washington, Seattle.
The compact analyzers facilitate rapid measurement of cholesterol and other lipid parameters outside the conventional laboratory setting. The current generation of instruments has very different features, operating parameters, and performance characteristics, and they must be selected in accordance with the intended application. All three of the common screening instruments, the DT-60, the Reflotron, and the VISION, have demonstrated the capability to meet current performance guidelines, provided they are operated correctly.
View Article and Find Full Text PDFBiochim Biophys Acta
September 1988
Northwest Lipid Research Center, University of Washington, Seattle.
Lecithin-cholesterol acyltransferase (LCAT) mass, activity and endogenous cholesterol esterification rate were measured in plasma and apolipoprotein A-I-free (A-I-free) plasma from two normolipidemic and two hyperlipidemic subjects, and from a patient with Tangier disease. A-I was removed from plasma by an anti-A-I immunosorbent. LCAT activity was measured using an exogenous substrate.
View Article and Find Full Text PDFClin Chem
August 1988
Northwest Lipid Research Center, Department of Medicine, University of Washington, Seattle 98104.
We conducted a proficiency survey of cholesterol and high-density lipoprotein (HDL) cholesterol analysis in local clinical laboratories to determine whether increased national emphasis on cholesterol measurement had resulted in changes in performance from previous surveys. Sets of frozen aliquots of plasma and HDL supernate pools were sent to nine laboratories for analysis; results were compared with Northwest Lipid Research Center values, and relationships were determined by linear regression. Of all the cholesterol measurements, 81% were considered acceptable (i.
View Article and Find Full Text PDF